|
SMYD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
9.64495150412858E-12 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.62725388719309E-12 |
| Stage1-vs-Stage2 |
5.963800E-01 |
| Stage1-vs-Stage3 |
9.449800E-01 |
| Stage1-vs-Stage4 |
1.649820E-01 |
| Stage2-vs-Stage3 |
5.805200E-01 |
| Stage2-vs-Stage4 |
6.134200E-01 |
| Stage3-vs-Stage4 |
2.157400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.399220E-03 |
| Normal-vs-Asian |
6.1390004191253E-11 |
| Caucasian-vs-AfricanAmerican |
1.905770E-01 |
| Caucasian-vs-Asian |
1.992050E-01 |
| AfricanAmerican-vs-Asian |
5.244400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.857600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.71764857681956E-14 |
| Normal-vs-Age(81-100Yrs) |
3.400800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.546400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.260600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.790000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.962200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.308610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.392400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.687800E-01 |
| Classical-VS-Follicular |
2.008400E-04 |
| Classical-VS-Other |
7.511600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.424100E-02 |
| Tall-VS-Other |
6.591800E-01 |
| Tall-VS-Normal |
3.47855078075554E-12 |
| Follicular-VS-Other |
1.572000E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
2.138800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.85247389544929E-14 |
| N0-vs-N1 |
9.115600E-01 |
|
|
